smitha wrote:As much as the PWC fees seem high, surely they are cheaper than what the directors were getting paid?
Now seems to be a good time for Dangote to swoop and acquire the firm on the cheap. Shareholders surely will be happy to see upwards of 10 bob a share compared to what CDC paid for a share.
Except for Paunrana, the rest of the management may still be around and getting paid for twiddling their thumbs.
The "problem" is the low production due to lack of cash means it still makes an operating loss.
I am not sure what happened between CDC and the Banks but Paunrana hinted at it in an interview.
Greedy when others are fearful. Very fearful when others are greedy - to paraphrase Warren Buffett